Docon Technologies Sells Shares of Thyrocare Technologies, Reducing Promoter Holding
Thyrocare Technologies Limited announced that its promoter, Docon Technologies Private Limited, sold equity shares of the company on Thursday, August 13, 2026.The transaction involved the sale of 157,69,696 equity shares through market trades. These shares represent approximately 9.90% of Thyrocare's total paid-up equity share capital.
Following the sale, the promoter shareholding in Thyrocare Technologies Limited has been adjusted. The holding level reduced from 60.92% to 51.02% of the company's total paid-up equity share capital.
Despite the reduction in stake, Docon Technologies Private Limited continues its role as a Promoter and holding company of Thyrocare Technologies Limited.
Financial details regarding the share transaction are summarized below:
| Metric | Details |
|---|---|
| Promoter | Docon Technologies Private Limited |
| Shares Sold | 157,69,696 equity shares |
| Magnitude of Sale | Approximately 9.90% of total paid-up equity share capital |
| Pre-Sale Promoter Holding | 60.92% |
| Post-Sale Promoter Holding | 51.02% |
THYROCARE Stock Price Movement
Shares of Thyrocare Technologies Limited slipped by 4.50% today, closing at ₹614 after shedding ₹28.95 during trading hours. The stock saw a total volume of 4.5 million shares as it trades within its range and continues to look toward the company's 52-week high of ₹662.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.